Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

Blood (2017) 130 (Supplement 1): 2678.

https://doi.org/10.1182/blood.V130.Suppl_1.2678.2678

Published: 2017

Journal Articles

Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

Blood (2017) 129 (10): 1397–1401.

https://doi.org/10.1182/blood-2016-10-745273

Published: 2017

Includes: Supplemental data

Journal Articles

Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation

Matt Christopher, MD PhD, Allegra A. Petti, PhD, Christopher Miller, PhD, Lukas D. Wartman, MD, Jacqueline E. Payton, MD PhD, Sharon Heath, Robert Fulton, John S. Welch, MD PhD, Matthew J. Walter, MD, Peter Westervelt, MD PhD, Daniel C. Link, MD, Richard K Wilson, PhD, Timothy J. Ley, MD, John F. DiPersio, MD, PhD

Blood (2016) 128 (22): 1528.

https://doi.org/10.1182/blood.V128.22.1528.1528

Published: 2016

Journal Articles

DNMT3A -Dependent DNA Methylation May Act As a Tumor Suppressor-Not a Tumor Promoter-during AML Progression

David Spencer, MDPhD, David Russler-Germain, Nichole M Helton, B.S., Tamara L Lamprecht, B.S., Marwan Shinawi, MD, Peter Westervelt, MD PhD, Jacqueline E. Payton, MD PhD, Robert S. Fulton, PhD, Richard K Wilson, PhD, Matthew J. Walter, MD, Daniel C. Link, MD, John F. DiPersio, MD, PhD, Timothy J. Ley, MD

Blood (2016) 128 (22): 1050.

https://doi.org/10.1182/blood.V128.22.1050.1050

Published: 2016

Journal Articles

Dynamic Changes in MDS Clonal Architecture Following Allogeneic Stem Cell Transplant

Meagan A. Jacoby, MD PhD, Eric J. Duncavage, MD, Gue Su Chang, PhD, Christopher A. Miller, PhD, Jin Shao, Kevin Elliott, Robert S. Fulton, PhD, Catrina Fronick, Michelle O'Laughlin, Daniel C. Link, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Timothy J. Ley, MD, Timothy A. Graubert, MD, Matthew J. Walter, MD, Richard K Wilson, PhD

Blood (2016) 128 (22): 5506.

https://doi.org/10.1182/blood.V128.22.5506.5506

Published: 2016

Journal Articles

Rare Pre-Existing MDS Subclones Contribute to Secondary AML Progression

Eric J. Duncavage, MD, Meagan A. Jacoby, MD PhD, Chris Miller, PhD, Gue Su Chang, PhD, Jin Shao, Kevin Elliot, Catrina Fronick, Michelle O'Laughlin, Robert Fulton, PhD, Richard K Wilson, PhD, Timothy A. Graubert, MD, Matthew J. Walter, MD

Blood (2016) 128 (22): 959.

https://doi.org/10.1182/blood.V128.22.959.959

Published: 2016

Journal Articles

Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML

Terrence N. Wong, Christopher A. Miller, Jeffery M. Klco, Allegra Petti, Ryan Demeter, Nichole M. Helton, Tiandao Li, Robert S. Fulton, Sharon E. Heath, Elaine R. Mardis, Peter Westervelt, John F. DiPersio, Matthew J. Walter, John S. Welch, Timothy A. Graubert, Richard K. Wilson, Timothy J. Ley, Daniel C. Link

Blood (2016) 127 (7): 893–897.

https://doi.org/10.1182/blood-2015-10-677021

Published: 2016

Includes: Supplemental data

Journal Articles

Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients

Terrence Neal Wong, MDPhD, Jeffery M. Klco, MDPhD, Ryan Demeter, Christopher A. Miller, PhD, Allegra Petti, PhD, Nichole Havey, Robert Fulton, PhD, Sharon Heath, Elaine R Mardis, PhD, Peter Westervelt, MD PhD, John F. DiPersio, MD PhD, Matthew J. Walter, MD, John S. Welch, MD PhD, Timothy Graubert, MD, Richard K Wilson, PhD, Timothy J. Ley, MD, Daniel C. Link, MD

Blood (2015) 126 (23): 686.

https://doi.org/10.1182/blood.V126.23.686.686

Published: 2015

Journal Articles

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Blood (2015) 126 (23): 689.

https://doi.org/10.1182/blood.V126.23.689.689

Published: 2015

Journal Articles

Expression of an Oncogenic ERG isoform Characterizes a Distinct Subtype of B-Progenitor Acute Lymphoblastic Leukemia

Jinghui Zhang, PhD, Kelly McCastlain, Chunxu Qu, PhD, Gang Wu, PhD, Michael Edmonson, PhD, Yongjin Li, PhD, Lei Wei, PhD, Debbie Payne-Turner, BS, Hiroki Yoshihara, MDPhD, Michelle L. Churchman, PhD, Esmé Waanders, PhD, Panagiotis Ntziachristos, PhD, Iannis Aifantis, PhD, Kathryn G. Roberts, Jing Ma, PhD, Guangchun Song, PhD, John Easton, PhD, Heather L. Mulder, BS, Xiang Chen, PhD, Michael Rusch, BA, Kristy Boggs, PhD, Bhavin Vadodaria, BS, James Dalton, BS, Marcus L Valentine, PhD, Li Ding, PhD, Charles Lu, PhD, Robert S. Fulton, PhD, Lucinda Fulton, PhD, Yashodan Tabib, PhD, Kerri Ochoa, Meenakshi Devidas, PhD, Deqing Pei, Cheng Cheng, PhD, William E. Evans, PharmD, Ching-Hon Pui, MD, Sima Jeha, MD, Richard C. Harvey, PhD, I-Ming L Chen, DVM, MS, Cheryl L. Willman, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD, Jessica Kohlschmidt, PhD BS, MS, Krzysztof Mrozek, MD PhD, Elisabeth Paietta, PhD, Martin S. Tallman, MD, Wendy Stock, MD, Peter M. Voorhees, MD, Janis Racevskis, MD, Jacob M. Rowe, MD, Selina Luger, MD, Steven M. Kornblau, MD, Sheila A Shurtleff, PhD, Susana C. Raimondi, PhD, Elaine R Mardis, PhD, Richard K Wilson, PhD, Stephen P Hunger, MD, Mignon L. Loh, MD, James R. Downing, MD, Charles G. Mullighan

Blood (2015) 126 (23): 693.

https://doi.org/10.1182/blood.V126.23.693.693

Published: 2015

Journal Articles

Detection of Clonal Hematopoiesis in Cytopenic Patients Using Targeted Sequencing

Eric J. Duncavage, MD, Jennifer O'Brien, MDPhD, Kiran R. Vij, MD, Chris A Miller, PhD, Jin Shao, Meagan A. Jacoby, MD PhD, Robert S. Fulton, PhD, Sharon Heath, Megan Janke, Catrina C. Fronick, Michelle O'Laughlin, Richard K Wilson, PhD, Timothy J. Ley, MD, Matthew J. Walter, MD

Blood (2015) 126 (23): 1654.

https://doi.org/10.1182/blood.V126.23.1654.1654

Published: 2015

Journal Articles

Recurrent Somatic Genomic Alterations in Follicular NHL (FL) Revealed By Exome and Custom-Capture Next Generation Sequencing

Todd A Fehniger, MD PhD, Kilannin Krysiak, PhD, Brian S White, PhD, Matthew Matlock, Chris Miller, Robert Fulton, PhD, Friederike Kreisel, MD, Catrina Fronick, Lisa Cook, Joelle Veizer, Amanda F. Cashen, MD, Kenneth R Carson, MD PhD, Melissa M Berrien-Elliott, PhD, Nancy L Bartlett, MD, Richard K Wilson, PhD, Elaine R Mardis, PhD, Timothy J Ley, Malachi Griffith, Obi L Griffith

Blood (2015) 126 (23): 574.

https://doi.org/10.1182/blood.V126.23.574.574

Published: 2015

Journal Articles

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Blood (2015) 126 (23): 610.

https://doi.org/10.1182/blood.V126.23.610.610

Published: 2015

Journal Articles

Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice

Elise Peterson Lu, Michael McLellan, Li Ding, Robert Fulton, Elaine R. Mardis, Richard K. Wilson, Christopher A. Miller, Peter Westervelt, John F. DiPersio, Daniel C. Link, Matthew J. Walter, Timothy J. Ley, Timothy A. Graubert

Blood (2014) 124 (26): 3887–3895.

https://doi.org/10.1182/blood-2014-06-582551

Published: 2014

Includes: Supplemental data

Journal Articles

Whole Genome Bisulfite Sequencing of Purified Mouse Promyelocytes Reveals Differentially Methylated Regions in Cells Expressing PML-Rara

Shamika Ketkar-Kulkarni, MS, Christopher B Cole, David H. Spencer, MDPhD, Angela M. Verdoni, PhD, Nichole Havey, Tamara Lamprecht, Vincent Magrini, PhD, Ryan T Demeter, Richard K. Wilson, PhD, Timothy J Ley, MD

Blood (2014) 124 (21): 3531.

https://doi.org/10.1182/blood.V124.21.3531.3531

Published: 2014

Journal Articles

Whole-Genome Bisulfite Sequencing of Primary AML Cells with the DNMT3A R882H Mutation Identifies Regions of Focal Hypomethylation That Are Associated with Open Chromatin

David H. Spencer, MDPhD, Bilal Al-Khalil, David Russler-Germain, Tamara Lamprecht, Nicole Havey, Robert S. Fulton, Michelle O'Laughlin, BS, Catrina Fronick, Richard K. Wilson, PhD, Timothy J. Ley, MD

Blood (2014) 124 (21): 608.

https://doi.org/10.1182/blood.V124.21.608.608

Published: 2014

Journal Articles

Incidence of Germline Mutations in Cancer-Predisposition Genes in Children with Hematologic Malignancies: a Report from the Pediatric Cancer Genome Project

Blood (2014) 124 (21): 127.

https://doi.org/10.1182/blood.V124.21.127.127

Published: 2014

Journal Articles

The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML

Terrence Neal Wong, MD PhD, Giridharan Ramsingh, M.D, Andrew Young, Dong Shen, Chris Miller, PhD, Tamara Lamprecht, B.S., Sharon Heath, Robert S. Fulton, Elaine R. Mardis, PhD, Li Ding, Peter Westervelt, MD, PhD, John Welch, PhD/MD, Matthew J. Walter, MD, Timothy Graubert, MD, John F. DiPersio, MD, PhD, Timothy J. Ley, MD, Todd E Druley, MD, PhD, Richard K Wilson, PhD, Daniel C. Link, MD

Blood (2013) 122 (21): 5.

https://doi.org/10.1182/blood.V122.21.5.5

Published: 2013

Journal Articles

Subclonal “skewing” Of De Novo AML Samples After Engraftment In Immunodeficient Mice

Jeffery M. Klco, MD/PhD, David H Spencer, MD/PhD, Christopher A Miller, PhD, Tamara Lamprecht, Dan George, Robert S. Fulton, Richard K Wilson, PhD, Timothy J. Ley, MD

Blood (2013) 122 (21): 609.

https://doi.org/10.1182/blood.V122.21.609.609

Published: 2013

Journal Articles

Genomic impact of transient low-dose decitabine treatment on primary AML cells

Jeffery M. Klco, David H. Spencer, Tamara L. Lamprecht, Shawn M. Sarkaria, Todd Wylie, Vincent Magrini, Jasreet Hundal, Jason Walker, Nobish Varghese, Petra Erdmann-Gilmore, Cheryl F. Lichti, Matthew R. Meyer, R. Reid Townsend, Richard K. Wilson, Elaine R. Mardis, Timothy J. Ley

Blood (2013) 121 (9): 1633–1643.

https://doi.org/10.1182/blood-2012-09-459313

Published: 2013

Includes: Supplemental data

NARROW

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation

DNMT3A -Dependent DNA Methylation May Act As a Tumor Suppressor-Not a Tumor Promoter-during AML Progression

Dynamic Changes in MDS Clonal Architecture Following Allogeneic Stem Cell Transplant

Rare Pre-Existing MDS Subclones Contribute to Secondary AML Progression

Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML

Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Expression of an Oncogenic ERG isoform Characterizes a Distinct Subtype of B-Progenitor Acute Lymphoblastic Leukemia

Detection of Clonal Hematopoiesis in Cytopenic Patients Using Targeted Sequencing

Recurrent Somatic Genomic Alterations in Follicular NHL (FL) Revealed By Exome and Custom-Capture Next Generation Sequencing

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice

Whole Genome Bisulfite Sequencing of Purified Mouse Promyelocytes Reveals Differentially Methylated Regions in Cells Expressing PML-Rara

Whole-Genome Bisulfite Sequencing of Primary AML Cells with the DNMT3A R882H Mutation Identifies Regions of Focal Hypomethylation That Are Associated with Open Chromatin

Incidence of Germline Mutations in Cancer-Predisposition Genes in Children with Hematologic Malignancies: a Report from the Pediatric Cancer Genome Project

The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML

Subclonal “skewing” Of De Novo AML Samples After Engraftment In Immunodeficient Mice

Genomic impact of transient low-dose decitabine treatment on primary AML cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only